Close
  Indian J Med Microbiol
 

Figure 2: Alternation cell proliferation and apoptosis, alkaline phosphatase, collagen type I, and content of MG-63 by AS treatment (*P < 0.05, vs. control group). (a) Astragaloside dose dependently upregulated cell viability compared with controls. (b) Astragaloside dose dependently downregulated cell apoptosis compared with controls. (c) Alkaline phosphatase activity showed a stepwise increase as the concentration of astragaloside treatment increased when compared with controls. (d) Collagen type I was dose dependently upregulated in cell treated with astragaloside. (e) Content of MG-63 treated with various doses of astragaloside showed a stepwise increase compared with controls

Figure 2: Alternation cell proliferation and apoptosis, alkaline phosphatase, collagen type I, and content of MG-63 by AS treatment (*<i>P</i> < 0.05, vs. control group). (a) Astragaloside dose dependently upregulated cell viability compared with controls. (b) Astragaloside dose dependently downregulated cell apoptosis compared with controls. (c) Alkaline phosphatase activity showed a stepwise increase as the concentration of astragaloside treatment increased when compared with controls. (d) Collagen type I was dose dependently upregulated in cell treated with astragaloside. (e) Content of MG-63 treated with various doses of astragaloside showed a stepwise increase compared with controls